<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The WFS1 gene encodes an endoplasmic reticulum (ER) membrane-embedded protein called <z:chebi fb="20" ids="27998">Wolfram</z:chebi> syndrome 1 protein, homozygous mutations of which cause selective beta cell loss in humans </plain></SENT>
<SENT sid="1" pm="."><plain>The function(s) of this protein and the mechanism by which the mutations of this gene cause beta cell <z:hpo ids='HP_0011420'>death</z:hpo> are still not fully understood </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesised that increased insulin demand as a result of <z:hpo ids='HP_0001513'>obesity</z:hpo>/<z:hpo ids='HP_0000855'>insulin resistance</z:hpo> causes ER stress in pancreatic beta cells, thereby promoting beta cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We studied the effect of breeding Wfs1 ( -/- ) mice on a C57BL/6J background with mild <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, by introducing the agouti lethal yellow mutation (A ( y ) /a) </plain></SENT>
<SENT sid="4" pm="."><plain>We also treated the mice with <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Wfs1 ( -/- ) mice bred on a C57BL/6J background rarely develop overt <z:mp ids='MP_0002055'>diabetes</z:mp> by 24 weeks of age, showing only mild beta cell loss </plain></SENT>
<SENT sid="6" pm="."><plain>However, Wfs1 ( -/- ) A ( y ) /a mice developed selective beta cell loss and severe insulin-deficient <z:mp ids='MP_0002055'>diabetes</z:mp> as early as 8 weeks </plain></SENT>
<SENT sid="7" pm="."><plain>This beta cell loss was due to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>In Wfs1 ( +/+ ) A ( y ) /a islets, levels of ER chaperone immunoglobulin-binding protein (BiP)/78 kDa <z:chebi fb="105" ids="17234">glucose</z:chebi>-regulated protein (GRP78) and phosphorylation of eukaryotic translation initiation factor 2, subunit alpha (eIF2alpha) apparently increased </plain></SENT>
<SENT sid="9" pm="."><plain>Levels of both were further increased in Wfs1 ( -/- ) A ( y ) /a murine islets </plain></SENT>
<SENT sid="10" pm="."><plain>Electron micrography revealed markedly dilated ERs in Wfs1 (-/-) A ( y ) /a murine beta cells </plain></SENT>
<SENT sid="11" pm="."><plain>Interestingly, <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> treatment protected beta cells from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and almost completely prevented <z:mp ids='MP_0002055'>diabetes</z:mp> development </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS/INTERPRETATION: Wfs1-deficient beta cells are susceptible to ER stress </plain></SENT>
<SENT sid="13" pm="."><plain>Increased insulin demand prompts <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in such cells in vivo </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="0" ids="8228">Pioglitazone</z:chebi>, remarkably, suppresses this process and prevents <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="15" pm="."><plain>As common WFS1 gene variants have recently been shown to confer a risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, our findings may be relevant to the gradual but progressive loss of beta cells in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>